NCT05257330

Brief Summary

An observational study will be conducted in the Department of Neurology at AlAzhar University Hospitals To study the etiological factors of non-compressive myelopathy in a sample of Egyptian patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 17, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

February 25, 2022

Status Verified

February 1, 2022

Enrollment Period

6 months

First QC Date

February 17, 2022

Last Update Submit

February 17, 2022

Conditions

MyelopathyNon-Compressive

Outcome Measures

Primary Outcomes (1)

  • To study the etiological factors of non-compressive myelopathy in a sample of Egyptian patients

    study the clinico-radiological profile of Non-compressive myelopathy

    6 months

Interventions

CSF ExaminationDIAGNOSTIC_TEST

Lumbar puncture for CSF Examination

Eligibility Criteria

Age2 Months - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with acute, subacute, or chronic neurologic dysfunction consistent with myelopathy

You may qualify if:

  • \- Patients with acute, subacute, or chronic neurologic dysfunction (motor and sensory deficit, sphincteric involvement, and a well-defined upper sensory segmental level) consistent with myelopathy (with or without coexisting encephalopathy, neuropathy, or radiculopathy).

You may not qualify if:

  • \) Patients of myelopathy who did not undergo magnetic resonance imaging (MRI) of the spinal cord. 2) Spinal cord compression on MRI explaining patient's neurologic dysfunction. 3) History of previous trauma, acute coma and patients with definite cerebral symptoms incompatible with spinal pathology (e.g., aphasia, hemianopia, neglect, facial involvement). 4) Motor neuron disease (MND) 5)Degenerative ataxias.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Hussein and Sayed Galal Hospitals

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Spinal Cord Diseases

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System Diseases

Study Officials

  • Mohie-eldin T Mohamed, Professor

    Al-Azhar Faculty of medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Islam S Al-Emam, MSC

CONTACT

+201027759946eslamsalman211@gmail.com

Abdel-Ghaffar Iٍ Fayed, Lecturer

CONTACT

+20 111 870 6806drfayed1984@azhar.edu.eg

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in Neurology

Study Record Dates

First Submitted

February 17, 2022

First Posted

February 25, 2022

Study Start

January 1, 2022

Primary Completion

June 30, 2022

Study Completion

July 31, 2022

Last Updated

February 25, 2022

Record last verified: 2022-02

Locations

EG(1)